Sfoglia per AUTORE
PURI T
Collezione AOU San Luigi di Orbassano
Items : 2
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC. in The New England journal of medicine / N Engl J Med. 2023 Nov 16;389(20):1839-1850. doi: 10.1056/NEJMoa2309457. Epub 2023 Oct 21.
2023
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Zhou C; Solomon B; Loong HH; Park K; Pérol M; Arriola E; Novello S; Han B; Zhou J; Ardizzoni A; Mak MP; Santini FC; Elamin YY; Drilon A; Wolf J; Payakachat N; Uh MK; Rajakumar D; Han H; Puri T; Soldatenkova V; Lin AB; Lin BK; Goto K;
RET Fusion-Positive Non-small Cell Lung Cancer: The Evolving Treatment Landscape. in The oncologist / Oncologist. 2023 May 8;28(5):402-413. doi: 10.1093/oncolo/oyac264.
2023
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Novello S; Califano R; Reinmuth N; Tamma A; Puri T;